1. Immunology/Inflammation
  2. AP-1
  3. JPC0661

JPC0661 是一种直接且变构的 ΔFOSB 抑制剂。JPC0661 以微摩尔级 IC50 值(9-52 μM) 抑制 ΔFOSB/JUND 和 ΔFOSB 与 DNA 的结合,在体外可直接抑制 ΔFOSB 介导的转录,其 IC50 值为 0.82 μM。JPC0661 在体内能显著降低 ΔFOSB 在基因组 AP1 位点的占据。JPC0661 通过结合于 ΔFOSB DNA 结合裂隙外的一个全新沟槽,破坏 ΔFOSB/JUND-DNA 复合物的形成。JPC0661 可用于阿尔茨海默病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

JPC0661

JPC0661 Chemical Structure

CAS No. : 30479-81-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

JPC0661 is a direct and allosteric ΔFOSB inhibitor. JPC0661 inhibits the binding of ΔFOSB/JUND and ΔFOsB to DNA with IC50 values in the micromolar range (9-52 uM), directly inhibits ΔFOSB-mediated transcription with IC50 of 0.82 μM in vitro. JPC0661 significantly reduces ΔFOSB occupancy at genomic AP1 sites in vivo. JPC0661 binds to a novel groove outside the DNA-binding cleft of ΔFOSB and disrupt the formation of the ΔFOSB/JUND-DNA complex. JPC0661 can be used for Alzheimer's disease research[1].

IC50 & Target[1]

FosB

 

体外研究
(In Vitro)

JPC0661 (0-100 μM) 可调节 ΔFOSB 驱动的基因表达,其 IC50 值为 0.82 μM,并可在HEK293 细胞中诱导 ΔFOSB 蛋白积累[1]
JPC0661 (0-100 μM,24 或 72 小时) 在神经祖细胞、AP1-luc HEK293 细胞以及 Neuro2A 细胞中均表现出良好的耐受性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Neuronal progenitor cells (NPC)
Concentration: 0.16, 0.31, 0.63, 1.25, 2.5, 5.00, 10.00 and 20 μM,
Incubation Time: 24,72 h
Result: Observed no discernable decrease after 24 h and only minimal losses after 72 h.
体内研究
(In Vivo)

JPC0661 ( 50 μM,给药量为 16.7 ng/h,持续 3 天) 能在表达携带瑞典突变 (K670N, M671L) 和印第安纳突变 (V717F) 的人源淀粉样前体蛋白 (APP) 的杂合转基因雄性和雌性小鼠中,导致 ΔFOSB 在其大多数正常基因组定位位点上的结合出现显著且广泛的减少[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Heterozygous transgenic male and female mice (2-3 months)[1]
Dosage: 50 μM in 0.2% DMSO/0.9% saline with 0.96 μL/h
Administration: intra-hippocampal infusion for 3 days
Result: Exhibited an approximately 60% reduction in total binding sites.
Decreased average peak width.
Directly disrupted ΔFOSB–DNA interactions.
Caused a modest decline in promoter proximal peaks (≤1 kb) and a relative enrichment in distal intergenic peaks.
分子量

347.35

Formula

C15H13N3O5S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
JPC0661
目录号:
HY-W471288
需求量: